Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome

CONCLUSION: MetS patients with elevated CysC levels have a higher risk of all-cause, CVD, and cancer death. CysC may predict MetS all-cause and CVD mortality.PMID:38597157 | DOI:10.1210/clinem/dgae225

Source: The Journal of Clinical Endocrinology and Metabolism - April 10, 2024 Category: Endocrinology Authors: Xiaoying Song Lijiao Xiong Tianting Guo Xue Chen Pinjun Zhang Xiaoan Zhang Zhen Liang Source Type: research